The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
8 marketed package NDCs · 5 active manufacturers
Most dispensed: 1200 mg; DEXTROMETHORPHAN HYDROBROMIDE 60 mg · Tablet, Extended Release · #2 blister packs/carton / 7 tablet, extended release in 1 blister pack · 600 mg; DEXTROMETHORPHAN HYDROBROMIDE 30 mg · Tablet, Extended Release · #2 blister packs/carton / 10 tablet, extended release in 1 blister pack · 1200 mg; DEXTROMETHORPHAN HYDROBROMIDE 60 mg · Tablet, Extended Release · #4 blister packs/carton / 7 tablet, extended release in 1 blister pack · 600 mg; DEXTROMETHORPHAN HYDROBROMIDE 30 mg · Tablet, Extended Release · #4 blister packs/carton / 10 tablet, extended release in 1 blister pack
5 companies supply this market — a reasonable cushion if one runs into trouble.
Every detected change for guaifenesin and dextromethorphan hbr, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.